|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Extrahepatic Bile Duct Cancer | |||||
| Gallbladder Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Bile Duct Neoplasms | |||||
| Cholangiocarcinoma | |||||
| Gallbladder Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Adenocarcinoma | |||||
| Bile Duct Diseases | |||||
| Biliary Tract Diseases | |||||
| Biliary Tract Neoplasms | |||||
| Carcinoma | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gallbladder Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| 4 | Interventions listed in this trial | ||||
| porfimer sodium | |||||
| biliary stenting | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Dihematoporphyrin Ether | |||||
| Trioxsalen | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Dermatologic Agents | |||||
| Pharmacologic Actions | |||||
| Photosensitizing Agents | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| University College London Hospitals | |||||